1. SAT0169 Maintenance and improvement in clinical efficacy between week 12 and 24 in patients with rheumatoid arthritis treated with sb4 or reference etanercept. (15th June 2017) Authors: Emery, P; Vencovsky, J; Keystone, E; Ghil, J; Cheong, SY; Hong, EE Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0089 M-DAS28, DAS28 (CRP) and RAPID3 scores at baseline are good predictors of radiographic disease progression at 1 and 2 years: data from the ample trial. (15th June 2017) Authors: Keystone, E; Ahmad, H; Yazici, Y; Muratti, E; Ye, J; Bergman, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0204 Impact of anti-drug antibody and injection site reaction on efficacy: 24-week results from a phase iii study comparing SB4 (etanercept biosimilar) with reference etanercept in patients with rheumatoid arthritis. (15th June 2017) Authors: Vencovsky, J; Emery, P; Keystone, E; Ghil, J; Cheong, SY; Hong, EE Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Infliximab in active early rheumatoid arthritis. Issue 2 (13th January 2004) Authors: Breedveld, F C; Emery, P; Keystone, E; Patel, K; Furst, D E; Kalden, J R; St Clair, E W; Weisman, M; Smolen, J; Lipsky, P E; Maini, R N Journal: Annals of the rheumatic diseases Issue: Volume 63:Issue 2(2004) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0086 The fully human anti-tnf monoclonal antibody, adalimumab (d2e7), dose ranging study: the 24-week clinical results in patients with active ra on methotrexate therapy (the armada trial). (1st June 2001) Authors: Keystone, E; Weinblatt, ME; Weisman, M; Furst, D; Paulus, H; Birbara, C; Fischkoff, S; Chartash, EK Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0121 Enbrel® (etanercept) vs. methotrexate (mtx) in early rheumatoid arthritis (era trial): two-year follow-up. (1st June 2001) Authors: Genovese, M; Martin, RW; Fleischmann, R; Keystone, E; Bathon, J; Spencer-Green, G; Finck, B Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0068 102-wk clinical and radiologic results from the attract trial: a 2 year, randomised, controlled, phase 3 trial of infliximab (remicade®) in pts with active ra despite mtx. (1st June 2001) Authors: Maini, R; Van der Heijde, D; Smolen, J; Kalden, J; Breedveld, F; Emery, P; Keystone, E; Harriman, G; Lipksy, P Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0187 Radiographic progression by disease activity states in patients with rheumatoid arthritis treated with sb2 or reference infliximab. (15th June 2017) Authors: Smolen, JS; Choe, J-Y; Keystone, E; Rho, YH; Lee, Y; Lee, S Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0203 Impact of adalimumab serum concentration on efficacy and association between ANTI-DRUG antibodies and serum concentration: 24 week results from a phase III study comparing SB5 (an adalimumab biosimilar) with reference adalimumab in patients with rheumatoid arthritis. (15th June 2017) Authors: Kay, J; Weinblatt, M; Keystone, E; Genovese, M; Ghil, J; Cheong, SY; Hong, EE Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A8.5 Baricitinib effects on serum cholesterol and circulating lipid particles in a phase 2B study in patients with rheumatoid arthritis. (13th February 2015) Authors: Kremer, J; Genovese, MC; Keystone, E; Taylor, P; Zuckerman, SH; Schlichting, DE; Beattie, SD; Macias, WL Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗